The 2024 Toronto PKD Scientific Day, held on November 15, 2024, was a hybrid (in person and virtual) conference to review the clinical features and pathobiology of ADPKD; update recent advances in PKD translational research; illustrate how advances in diagnostic and therapeutic may impact clinical practice; and hold an expert discussion of challenging clinical cases. The 2024 KDIGO ADPKD guidelines were incorporated in all clinical recommendations wherever possible.

YouTube playlist of all sessions

Agenda:

1. Welcome & Overview of Conference | York Pei | 2024 TO PKD Conference
2. PKD Pathobiology: What You Need to Know as a Clinician | Terry Watnick | 2024 TO PKD Conference
3. Management of ADPKD in 2024: What Do Clinicians Need to Know? | Ron Perrone | 2024 TO PKD Conference
4. Utility and Nuances of TKV Measurements | Korosh Khalili | 2024 TO PKD Conference
5. Next Generation Volumetric for ADPKD | Tim Kline | 2024 TO PKD Conference
6. Practical Guidelines for Treatment with V2R Antagonist in ADPKD | Vicente Torres | 2024 TO PKD Conference
7. Promising New Therapies in the Next Decade and Beyond | Gregory Germino | 2024 TO PKD Conference
8. Introduction: Clinical Burden of PLD in ADPKD | York Pei | 2024 TO PKD Conference
9. A Patient’s Journey through PLD | Bill Wang | 2024 TO PKD Conference
10. Medical Management of PLD | Vicente Torres | 2024 TO PKD Conference
11. Foam Sclerotherapy for PLD | Eran Shlomovitz | 2024 TO PKD Conference
12. Surgical Management of PLD | Sean Cleary | 2024 TO PKD Conference
13. Optimal Management and Unmet Needs of PLD Care | All Faculty Speakers | 2024 TO PKD Conference

The target audience is nephrologists, internists, medical geneticists, radiologists, clinical trainees, nurses, patient advocates (including the PKD Foundation of Canada), patients and their family members.

PDF of Program

KDIGO Guidelines

YouTube playlist of all sessions